Breast Cancer Risk Assessment and Treatment

Article

Personalized medicine is here. It's the responsibility of OB/GYNs, other women's health care clinicians, and primary care providers to understand how it can impact the decisions we and our patients make.

Read two case studies demonstrating the many ways in which genetic testing, breast cancer prognostic tests, and personalized medicine have improved the very foundation of patient care in this area.

Watch the associated video, below!

Learn How SNPs May Assist in Assessing Breast Cancer Risks for Your Patients

  

 

Recent Videos
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Wasson and Colak
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
© 2025 MJH Life Sciences

All rights reserved.